Ashley Mains Espinosa, PharmD, MS, CPHIMS

The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.

The 340B Drug Pricing Program contains several complexities that covered entities are expected to govern and oversee.

Among the most important members of the 340B team of a covered entity (CE) are the software vendors.

Certain institutional providers are required to file a Medicare cost report annually to CMS, which uses that information to set prospective payment rates and determine if Medicare overpaid or underpaid a given institution during the submitted fiscal year.